BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of long half-life antibacterials. 1979

F Follath

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex

Related Publications

F Follath
Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modeling.
January 1997, European journal of drug metabolism and pharmacokinetics,
F Follath
Pharmacokinetics of antibacterials in calves.
July 1982, The Veterinary record,
F Follath
Long half-life of chlorpheniramine.
March 1979, The New England journal of medicine,
F Follath
Interethnic differences in pharmacokinetics of antibacterials.
March 2015, Clinical pharmacokinetics,
F Follath
Prediction of human pharmacokinetics of long half-life compounds using chimeric mice with humanised liver.
December 2019, Xenobiotica; the fate of foreign compounds in biological systems,
F Follath
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life.
January 1981, Chemotherapy,
F Follath
Long plasma half-life of pyrimethamine.
July 1973, Lancet (London, England),
F Follath
Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
June 1998, Clinical pharmacokinetics,
F Follath
[Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability].
January 1999, L'Encephale,
F Follath
Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
July 2013, Clinical pharmacokinetics,
Copied contents to your clipboard!